Sangamo Therapeutics announces proposed public offering of common stock
Sangamo Therapeutics announced it has commenced an underwritten public offering of $200.0 million of shares of its common stock. In addition, Sangamo expects to grant underwriters of the offering a 30-day option to purchase up to an additional $30.0 million of shares of its common stock. April 24, 2018